{"disease":{"id":"anaphylactic-shock","name":"anaphylactic shock"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06192914","title":"EPAP, Interviewstudy","phase":"","overall_status":"RECRUITING","enrollment_count":322,"lead_sponsor_name":"Charite University, Berlin, Germany","has_results":false},{"nct_id":"NCT02886468","title":"DEpth of EPinephrine Delivery With Auto-injectors Devices","phase":"NA","overall_status":"COMPLETED","enrollment_count":107,"lead_sponsor_name":"Centre Hospitalier Régional Metz-Thionville","has_results":false},{"nct_id":"NCT06316414","title":"Omalizumab in Severe Asthmatics With Food Allergy","phase":"","overall_status":"COMPLETED","enrollment_count":65,"lead_sponsor_name":"Bambino Gesù Hospital and Research Institute","has_results":false}],"total":3},"guidelines":[],"source":"Drug Landscape verified database"}